As part of our mini-Spotlight on proteomics, we carried out a survey to gain an insight into the trends, challenges and developments associated with proteomics R&D – find out the results in this informative infographic.
To kick-start this special focus, we wanted to hear your thoughts on the topic – complete our short survey on cellular and gene therapy to be the first to receive our informative infographic collated from the survey results.
Overcoming the challenges in bioanalysis of oligonucleotide-based therapies and relevance to the clinical development plan
Hugh M. Davis Chief Business Officer, Frontage Laboratories, Inc., Exton, Pennsylvania (PA, USA) As CBO…
We look at some of the highlights of our Twitter chat (#TalkProteomics), where we questioned panelists John Wilson, Ben Orsburn, Matthias Trost and Eduardo Chicano Gálvez about all things proteomics – from mass spectrometry to drug discovery.
Challenges and opportunities in bioanalytical support for gene therapy medicinal product development
This review article from Bioanalysis> summarizes recent practices and considerations in bioanalytical support of pharmacokinetics and pharmacodynamics evaluations in gene therapy development with insight into method design, development and validations.
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 – LBA/cell-based assays: immunogenicity, biomarkers and PK assays)
This part the 2018 White Paper published in Bioanalysis covers the recommendations for large molecule bioanalysis, biomarkers and immunogenicity using LBA and cell-based assays.
In this mini-Spotlight we will be exploring the role of bioanalysis is cellular and gene therapies.
We talk to Vellalore Kakkanaiah about his work using flow cytometry in adoptive cell therapy in this interview as part of our author’s perspective series.
Join us for our Twitter chat with proteomics experts on Friday 22nd February at 15:00 [GMT], 10:00 [EST], where we will discuss the applications of proteomics, mass spectrometry techniques and the challenges of proteomics research #TalkProteomics.
An author’s perspective: Zhengqi Ye on approaches to measure protein binding of enzymatically unstable compounds
We talk to Zhengqi Ye about the approaches she uses to measure protein binding of enzymatically unstable compounds in plasma in this interview as part of our author’s perspective series.